Top insights from the latest market news from Monday, March 23, from The Motley Fool analysts on Team Rule Breakers and Team ...

Volatility has spiked this year, and the S&P 500 (\^GSPC +1.64%) seems to be swinging every day based on the la ...

MP Materials aims to capitalize on a U.S. push to secure critical minerals and rare-earth elements. The company has ...

CrowdStrike is demonstrating some serious growth and is emerging as a market leader in cybersecurity. Here's why it's worth ...

Refunds for the 2025 tax year are shaping up to come in much higher than the previous year. President Donald Trump's ...

But even before it might obtain approval for its key drug, VK2735, there could be a catalyst that gives the healthcare stock ...

An HSA might give you even more tax breaks and flexibility. When it comes to saving for retirement, most people focus on ...

At the end of 2025, Wedbush Securities analyst Dan Ives, one of Wall Street's most outspoken tech bulls, predicted the ...

FuboTV announced it would execute a 1-for-12 reverse split at the end of the day today. The split was previously announced on ...

ImmunityBio recently won another approval for its oncology drug Anktiva. Although this approval in and of itself doesn’t ...

AbbVie (ABBV 0.27%) is a top healthcare stock, but it isn't trading like one of late. This year, it's down 11%, and it has ...

Ford is investing heavily in producing low-cost electric vehicles while Tesla is focusing on developing its robotaxi business ...